🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

25 years ago, I came to Stanford on a J1 visa and worked so hard to be worthy of that privilege. Today, I lead Immunology at Mount Sinai and I am the one who feel privileged when brilliant international students chose to join us.

Incredible! Over the past 2 months, 5 independent manuscripts — from The Colonna Lab, Dan Littman, Gardner Lab and Chrysothemis Brown, and our own (now in nature nature.com/articles/s4158…), reports that the dietary pTreg program is initiated by RORγt⁺ antigen-presenting cells. /1

For the immunologists still on X science.org/doi/10.1126/sc…

penntoday.upenn.edu/news/improving…

We previously showed that IFNg is required for CAR-T efficacy in solid tumors, but is it always good? Here, we show that IFNg limits CD28 CAR-T cells and that protection from this signal drives greater antitumor activity and durability. Enjoy! science.org/doi/10.1126/sc…

Ohh - so cool. For lovers of THE interferon.

Microbial Pathogenesis Peeps - New Investigators - this one is for you! Easy first round one pager. Break out your imagination and think of those high risk-reward projects and risks you want to take.... bwfund.org/funding-opport…

Sharing Dr Marina Seady’s comprehensive review published in Trends in Neuroscience regarding CD8 T cell mediated blood-brain barrier disruption. Great job Marina! Marina Seady lnkd.in/gPZsTA4j

Ever wondered about IL-12 toxicity? Here we build off Garcia labs and Synthekine to de-couple immune parameters and toxicity associated with IL-12 agonism: Cell Reports cell.com/cell-reports/f…

Get your proposal together for BWF PATH's 2026 awards! Letter of Intent deadline is July 17, 2025

Drawing attention to our senior immunology student Mark Maynes who published his MRI and spectral flow cytometry methods to measure neuroinflammation and neurodegeneration in dementia models. Nice job Mark! Mark Maynes sciencedirect.com/science/articl…

ITCH revolutionized veterinary medicine and what is considered a BLOCKBUSTER drug and a major indication. Apoquel (JAK inhibitor) was approved in 2013 for canines and literally sold like hotcakes. Itch in dogs is now a $multiBILLION dollar market: 🧵

What a week: I was lucky enough to get an ERC Advanced Grant, a Wellcome Trust Discovery award, and my fab colleagues at Inflammazoom nominated me for this BSI award. Thank you so much x.com/britsocimm/sta…

Improving T-cell responses to vaccines ft. Emily Aunins (@CAMBUPenn), ChrisHunter, Anthony Phan (@PennVet), Susan Domchek (Penn Medicine - Abramson Cancer Center), The Drew Weissman Lab (Penn Medicine), Mohamad-Gabriel Alameh (Penn Path & Lab Medicine) & Hensley Lab (Penn Microbiology) Science Immunology tinyurl.com/2p8xztbz

New in Science Immunology! @EmilyAunins, Dr. Anthony Phan, and their colleagues in the The Drew Weissman Lab and Hunter Lab (ChrisHunter) used lipid nanoparticles encoding IL-12 to boost CD8 T cell responses to mRNA vaccines. 📃 bit.ly/3G24jZL 🎧 bit.ly/4n7qA96

Subscribe on the PATH website to get details of upcoming general information Zooms ahead of the letter of intent deadline.